Brief Summary
The aim of this study is to evaluate the safety and feasibility of Endobronchial thermal liquid ablation (ETLA-LC) for the Treatment of Pulmonary Cancer Lesions.
Intervention/Treatment
- Device: Endobronchial Thermal Liquid Ablation – Lung Cancer (ETLA-LC).
Inclusion Criteria
General Inclusion Criteria:
- Age greater than or equal to 18 years old.
- Non-small cell lung cancer tumor(s) suitable for lobectomya surgical procedure where a lobe of an organ (e.g. the lung) is removed.
- Suitable candidate for lobectomy as per standard of care.
- Pathologically confirmed malignancy obtained via bronchoscopic biopsyremoval of a section of tissue to analyse for cancer cells with adequate yield to perform definitive diagnosis.
- Cognitively able to provide written informed consent.
Radiographic Inclusion Criteria
- Longest axis of tumor less than 3cm per HRCT analysis by QCT Core lab.
- Tumor is identified in the periphery of lung (outer 2/3rd) by radiologic reviewer in addition to site radiologist.
- Tumor resides in eligible segment(s) per HRCT analysis by QCT Core lab, with target treatment location not adjacent to lobar fissure planned for resection, and assessed by surgeon.
- Tumor resides within two or fewer eligible segments per HRCT analysis by QCT Core lab with treatment at the segmental or subsegmental level.